Clinical Trials for Myasthenia Gravis

Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis

NCT ID: NCT05979688

This clinical trial is exploring how a 6-week online program of yogic breathing exercises might help improve breathing, speech, and emotional well-being in people living with amyotrophic lateral sc...

Vitaccess Real MG Registry

NCT ID: NCT06064461

The Vitaccess Real MG Registry is a long-term study aimed at understanding myasthenia gravis (MG), a condition that affects muscle strength. This registry will collect information from around 600 p...

A Study in Patients With Myasthenia Gravis in China

NCT ID: NCT06700616

This clinical trial is studying how myasthenia gravis (MG) affects patients in China. It aims to understand the current treatment methods, how patients feel about their condition, and how the disea...

A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

NCT ID: NCT06869278

This clinical trial is looking at a new treatment called LCAR-AIO CAR-T cells for adults who have certain neurological autoimmune diseases, such as Multiple Sclerosis (MS), Neuromyelitis Optica Spe...

Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

NCT ID: NCT07022197

This clinical trial is studying a new treatment called BAFF-R CART for patients with certain neuroimmune diseases, including Chronic Inflammatory Demyelinating Polyradiculoneuropathy, NMO Spectrum ...

Application of Artificial Intelligence in Precision Medicine and Healthcare

NCT ID: NCT06879210

This clinical trial is exploring the use of smart technology to help people with myasthenia gravis, a condition that affects muscle strength. The main goal of the study is to develop an intelligent...

Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China

NCT ID: NCT04535843

This clinical trial is studying myasthenia gravis (MG), a condition that causes muscle weakness and fatigue. The researchers aim to better understand how to diagnose and track the progress of MG in...

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

NCT ID: NCT06939166

This clinical trial is studying a new treatment called Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) therapy, specifically aimed at helping patients with certain neurological autoimmune ...

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

NCT ID: NCT05265273

This clinical trial is studying a medication called nipocalimab for children and teenagers aged 2 to less than 18 years who have a condition known as generalized myasthenia gravis (gMG). gMG causes...

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT ID: NCT01793168

The Coordination of Rare Diseases at Sanford (CoRDS) is a clinical trial aimed at creating a large, centralized registry for individuals affected by rare diseases. This registry helps connect patie...

Serum Auto-Antibodies in Neurological Diseases

NCT ID: NCT00704626

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

NCT ID: NCT06978738

This clinical trial is looking at a new treatment called UCAR T-cell therapy for patients who have certain autoimmune diseases, like Systemic Lupus Erythematosus and Myasthenia Gravis, that have no...

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

NCT ID: NCT06940323

The PRISMA study is a research project that aims to gather important information about pregnancy in women who have certain chronic neurological conditions, like Multiple Sclerosis and Myasthenia Gr...

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

NCT ID: NCT04951622

This clinical trial is studying a new treatment called nipocalimab for adults with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. The main goal is to see if nipocalim...

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

NCT ID: NCT06933563

This clinical trial, called UCAR T-cell Therapy, is exploring a new treatment for patients with relapsed or refractory Myasthenia Gravis, a condition that affects muscle strength and can make every...

Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis

NCT ID: NCT06371040

This clinical trial is studying a new treatment called CD19-BCMA CAR-T therapy for adults with a severe form of Myasthenia Gravis (MG) that has not responded to other treatments. Myasthenia Gravis ...

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

NCT ID: NCT06414954

This clinical trial is studying a new medication called NMD670 to see how safe it is and how well it works for adults with Myasthenia Gravis (MG), a condition that affects muscle strength. The tria...

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

NCT ID: NCT05564936

The ME&MG clinical trial is studying a new digital tool called ME&MG, which helps people with Myasthenia Gravis (MG) assess their symptoms at home using their smartphones. This tool allows patients...

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT ID: NCT06220201

This clinical trial is studying a new medication called CC-97540 to see how safe it is, how well it works, and how it is processed in the body for people with Multiple Sclerosis (MS). The trial is ...

Capturing Key MG-symptoms Using Smartphone Recordings.

NCT ID: NCT06743490

This clinical trial, titled "Capturing Key MG-symptoms Using Smartphone Recordings," is designed to study the symptoms of Myasthenia Gravis (MG), a condition that causes muscle weakness and fatigue...